Search results
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 3 days agoTakeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days ago“We are proud to make SIMLANDI available in the U.S. to...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 3 days agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...
6 Signs of an Autoimmune Disease That Can Be Easy to Miss
Self via Yahoo News· 7 days agoA few other notable autoimmune conditions that can cause joint issues? Lupus (one type that attacks...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 4 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
What To Know and Do About Arthritis Pain
Health via Yahoo News· 6 days agoArthritis is a condition that causes pain, stiffness, and inflammation in your joints. Fortunately, medications and home remedies can help relieve pain.
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 4 days agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 3 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 2 days agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 3 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...